The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Chimpanzee Adenovirus Vector Ebola Vaccine
Open accessAbstract
BACKGROUND: The unprecedented 2014 epidemic of Ebola virus disease (EVD) prompted an international response to accelerate the availability of a preventive vaccine. A replication-defective recombinant chimpanzee adenovirus type 3-vectored ebolavirus vaccine (cAd3-EBO), encoding the glycoprotein from Zaire and Sudan species, that offers protection in the nonhuman primate model, was rapidly advanced into phase 1 clinical evaluation. METHODS: particle units. Primary and secondary end points related to safety and immunogenicity were assessed throughout the first 8 weeks after vaccination; in addition, longer-term vaccine durability was assessed at 48 weeks after vaccination. RESULTS: particle-unit dose. CONCLUSIONS: particle-unit dose, glycoprotein Zaire-specific antibody responses were in the range reported to be associated with vaccine-induced protective immunity in challenge studies involving nonhuman primates, and responses were sustained to week 48. Phase 2 studies and efficacy trials assessing cAd3-EBO are in progress. (Funded by the Intramural Research Program of the National Institutes of Health; VRC 207 ClinicalTrials.gov number, NCT02231866 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets
Roederer, M., Nozzi, J. L., & Nason, M. C. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21015 · Cited by 831
Self-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
Self-citationA system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z.-Y., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 462
Self-citationNovel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003155 · Cited by 405
Self-citationStanley, D. A., Honko, A. N., Asiedu, C., Trefry, J. C., Lau-Kilby, A. W., Johnson, J. C., Hensley, L., Ammendola, V., Abbate, A., Grazioli, F., et al. (2014) · Nature Medicine · doi:10.1038/nm.3702 · Cited by 350
Self-citationA monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E. B., Payne, R., Fehling, S. K., Strecker, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1411627 · Cited by 348
Self-citationA DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
Martin, J. E., Sullivan, N. J., Enama, M. E., Gordon, I. J., Roederer, M., Koup, R. A., Bailer, R. T., Chakrabarti, B. K., Bailey, M. A., Gomez, P. L., et al. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00162-06 · Cited by 235
Self-citationSullivan, N. J., Martin, J. E., Graham, B. S., & Nabel, G. J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2129 · Cited by 226
Self-citationSullivan, N. J., Hensley, L., Asiedu, C., Geisbert, T. W., Stanley, D., Johnson, J., Honko, A., Olinger, G., Bailey, M., Geisbert, J. B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2447 · Cited by 225
Self-citationTapia, M. D., Sow, S. O., Lyke, K. E., Haidara, F. C., Diallo, F., Doumbia, M., Traore, A., Coulibaly, F., Kodio, M., Onwuchekwa, U., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00362-x · Cited by 215
Self-citationLedgerwood, J. E., Costner, P., Desai, N., Holman, L., Enama, M. E., Yamshchikov, G., Mulangu, S., Hu, Z., Andrews, C. A., Sheets, R. A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.037 · Cited by 210
Self-citationSullivan, N. J., Geisbert, T. W., Geisbert, J. B., Shedlock, D. J., Xu, L., Lamoreaux, L., Custers, J. H. H. V., Popernack, P. M., Yang, Z.-Y., Pau, M. G., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030177 · Cited by 205
Self-citationSantis, O. D., Audran, R., Pothin, E., Warpelin‐Decrausaz, L., Vallotton, L., Wuerzner, G., Cochet, C., Estoppey, D., Steiner-Monard, V., Lonchampt, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00486-7 · Cited by 156
Self-citationImmunopathology of highly virulent pathogens: insights from Ebola virus
Zampieri, C. A., Sullivan, N. J., & Nabel, G. J. (2007) · Nature Immunology · doi:10.1038/ni1519 · Cited by 146
Self-citationChurchyard, G., Morgan, C. A., Adams, E. M., Hural, J., Graham, B. S., Moodie, Z., Grove, D., Gray, G., Bekker, L., McElrath, M. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021225 · Cited by 142
Self-citationSarwar, U. N., Costner, P. J. M., Enama, M. E., Berkowitz, N. C., Hu, Z., Hendel, C. S., Sitar, S., Plummer, S. H., Mulangu, S., Bailer, R. T., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu511 · Cited by 134
Self-citationQuinn, K. M., Costa, A. D. S., Yamamoto, A., Berry, D., Lindsay, R. W. B., Darrah, P. A., Wang, L., Cheng, C., Kong, W., Gall, J. G. D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202861 · Cited by 114
Self-citationKuhn, J. H., Bào, Y., Bavari, S., Becker, S., Bradfute, S. B., Brister, J. R., Bukreyev, A. A., Caì, Y., Chandran, K., Davey, R. A., et al. (2013) · Archives of Virology · doi:10.1007/s00705-012-1594-2 · Cited by 60
Self-citationAnti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
Porobič, J. M., Avčin, T., Božič, B., Kuhar, M., Čučnik, S., Zupančič, M., Prosenc, K., Kveder, T., & Rozman, B. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02923.x · Cited by 60
Paris, R., Kuschner, R. A., Binn, L. N., Thomas, S. J., Colloca, S., Nicosia, A., Cortese, R., Bailer, R. T., Sullivan, N. J., & Koup, R. A. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00011-14 · Cited by 28
Self-citation
Research works printed but not linked: 2
- 10.1128/JVI.77.18.9733-9737.2003 · doi:10.1128/jvi.77.18.9733-9737.2003
- 10.1586/14760584.2014.885841 · doi:10.1586/14760584.2014.885841
Cited by
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E. B., Payne, R., Fehling, S. K., Strecker, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1411627 · Cited by 348
Self-citationBarrett, J. R., Belij-Rammerstorfer, S., Dold, C., Ewer, K. J., Folegatti, P. M., Gilbride, C., Halkerston, R., Hill, J., Jenkin, D., Stockdale, L., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01179-4 · Cited by 315
Antibodies to combat viral infections: development strategies and progress
Pantaleo, G., Correia, B., Fenwick, C., Joo, V. S., & Perez, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 279
Huttner, A., Dayer, J.-A., Yerly, S., Combescure, C., Auderset, F., Desmeules, J., Eickmann, M., Finckh, A., Goncalves, A. R., Hooper, J. W., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00154-1 · Cited by 272
Metadata
- Authors
- Ledgerwood, J. E., DeZure, A. D., Stanley, D. A., Coates, E. E., Novik, L., Enama, M. E., Berkowitz, N. M., Hu, Z., Joshi, G., Ploquin, A., Sitar, S., Gordon, I. J., Plummer, S. A., Holman, L. A., Hendel, C. S., Yamshchikov, G., Roman, F., Nicosia, A., Colloca, S., Cortese, R., Bailer, R. T., Schwartz, R. M., Roederer, M., Mascola, J. R., Koup, R. A., Sullivan, N. J., & Graham, B. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-03-09
- Volume
- 376
- Issue
- 10
- Pages
- 928-938
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2155802193
- Cited by
- 285
- References
- 23
- FWCI
- 24.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.